H2AX and plasma cell myeloma: Immunofluorescence analysis of bone marrow samples from both pretreatment and post‐treatment myeloma patients demonstrated elevated expression of phosphorylated histone H2A.X and STING in myeloma cells of the post‐treatment group (Figure 3K).